Biography and Research Information
OverviewAI-generated summary
Abedalrahman Almashayekh's research focuses on acute kidney injury (AKI) and hypophosphatemia in patients undergoing chimeric antigen receptor (CAR) T-cell therapy. Almashayekh has investigated the clinical characteristics and mortality impact of AKI in this patient population, as well as identifying risk factors associated with its development. Additionally, research has explored the relationship between hypophosphatemia and immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR T-cell recipients, suggesting hypophosphatemia may serve as a marker for neurotoxicity. Almashayekh also contributed to a case series on SGLT2 inhibitors for hypomagnesemia. Key collaborators include Rahaf Omaish, Nithin Karakala, Lean Alkhatib, and Nishank Jain, all from the University of Arkansas for Medical Sciences, with whom Almashayekh has co-authored multiple publications.
Metrics
- h-index: 1
- Publications: 6
- Citations: 1
Positions
-
Fellow 2024–presentUniversity of Arkansas for Medical Sciences Nephrology ORCID
Selected Publications
-
Acute Kidney Injury in Recipients of Chimeric Antigen Receptor T-Cell therapy: Clinical Characteristics and Impact on Mortality (2026)
-
Relationship of hypophosphatemia to Immune Effector Cell-Associated Neurotoxicity Syndrome in chimeric antigen receptor T cell recipients (2026)
-
AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics (2025)
-
Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients (2025)
-
Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy (2025)
-
SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series (2025)
Collaboration Network
Top Collaborators
- Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy
- Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- Acute Kidney Injury in Recipients of Chimeric Antigen Receptor T-Cell therapy: Clinical Characteristics and Impact on Mortality
- Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- Acute Kidney Injury in Recipients of Chimeric Antigen Receptor T-Cell therapy: Clinical Characteristics and Impact on Mortality
- Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- Acute Kidney Injury in Recipients of Chimeric Antigen Receptor T-Cell therapy: Clinical Characteristics and Impact on Mortality
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- Acute Kidney Injury in Recipients of Chimeric Antigen Receptor T-Cell therapy: Clinical Characteristics and Impact on Mortality
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- Acute Kidney Injury in Recipients of Chimeric Antigen Receptor T-Cell therapy: Clinical Characteristics and Impact on Mortality
- SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series
- SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series
- SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series
- SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series
- SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series
- SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series
- SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series
- Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy
- Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy
Similar Researchers
Based on overlapping research topics